Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Patient Blood Management Market Research Report Information By Product (Instruments, Accessories, Reagents and Kits, Software), By Component (Whole Blood, Plasma), By End-User (Blood Banks, Hospitals, Diagnostic Clinics, Pathology Labs), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/HC/7326-HCR | 112 Pages | Author: Kinjoll Dey| April 2024

Market Segmentation


Patient Blood Management Product Outlook (USD Billion, 2018-2032)




  • Instruments




  • Accessories




  • Reagents and Kits




  • Software




Patient Blood Management Component Outlook (USD Billion, 2018-2032)




  • Whole Blood




  • Plasma




Patient Blood Management End-User Outlook (USD Billion, 2018-2032)




  • Blood Banks




  • Hospitals




  • Diagnostic Clinics




  • Pathology Labs




Patient Blood Management Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • North America Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • North America Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • US Outlook (USD Billion, 2018-2032)




    • US Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • US Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • US Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • Canada Outlook (USD Billion, 2018-2032)




    • Canada Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Canada Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Canada Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Europe Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Europe Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Germany Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Germany Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • France Outlook (USD Billion, 2018-2032)




    • France Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • France Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • France Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • UK Outlook (USD Billion, 2018-2032)




    • UK Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • UK Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • UK Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • Italy Outlook (USD Billion, 2018-2032)




    • Italy Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Italy Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Italy Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • Spain Outlook (USD Billion, 2018-2032)




    • Spain Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Spain Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Spain Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Rest Of Europe Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Rest Of Europe Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Asia-Pacific Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Asia-Pacific Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • China Outlook (USD Billion, 2018-2032)




    • China Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • China Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • China Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Japan Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Japan Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • India Outlook (USD Billion, 2018-2032)




    • India Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • India Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • India Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Australia Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Australia Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Rest of Asia-Pacific Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Rest of Asia-Pacific Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Rest of the World Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Rest of the World Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Middle East Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Middle East Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Africa Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Africa Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Patient Blood Management by Product




      • Instruments




      • Accessories




      • Reagents and Kits




      • Software






    • Latin America Patient Blood Management by Component




      • Whole Blood




      • Plasma






    • Latin America Patient Blood Management by End-User




      • Blood Banks




      • Hospitals




      • Diagnostic Clinics




      • Pathology Labs







Research Methodology on Patient Blood Management Market


Abstract


This report examines the current and future market potential of patient blood management through an in-depth analysis of the different market dynamics such as the drivers, factors impacting the growth of the industry, industry trends, and opportunities. It analyses the various end users and their regional trends to provide a comprehensive overview of the patient blood management landscape. Moreover, this report provides a detailed evaluation of the government regulations and their engagement and also offers an estimation of the growth prospects during the forecast period from 2023 to 2030.


Research Methodology


The research conducted to develop this report analyses the current and future market potential of the patient blood management industry. The data was collected through a comprehensive analysis of the market dynamics such as the drivers, factors impacting the growth of the industry, industry trends, and opportunities. Additionally, data was gathered from various end users to gain insight into the regional trends and provide the most comprehensive overview of the patient blood management landscape.


To collect the data required for the report, both primary and secondary research methods were used. Primary research methods involve contacting industry experts and stakeholders involved in the industry, as well as collecting first-hand data from them. On the other hand, secondary research methods include analyzing reports and statistics from various trade journals, government publications, and news websites. Additionally, these data sources allowed the researchers to verify the accuracy of the collected information.


In the first stage of the primary research, in-depth interviews were conducted with leading industry experts to gain a better understanding of the market and its industry-wide trends. Moreover, to fully evaluate the current industry standards, these interviews also included questions regarding the regulations and their engagement related to the patient blood management market. Additionally, these in-depth interviews also provided insight into the growth potential of the market during the forecast period from 2023 to 2030.


In the second stage of the primary research process, surveys were conducted by contacting customers, suppliers, distributors, and retailers directly through emails or telephonic conversations. These surveys helped provide a clear picture of customer satisfaction, pricing comparisons, industry-wide supply chains and other parameters required for analyzing the market and its potential. Moreover, these surveys also helped develop a comprehensive understanding of the regional and local industry trends, allowing researchers to tailor the market report according to the preferences of the customers.


The analysis of the gathered data was done using both quantitative and qualitative techniques. Moreover, the comparison of the industry trends between different periods was done using various graphical representations such as tables, bar charts, and market maps. On the other hand, qualitative methods such as market analysis and demand forecasting were used to accurately predict the market potential and develop a more realistic estimate of the growth prospects during the forecast period from 2023 to 2030.


In conclusion, the data collected through a combination of both primary and secondary research methods, as well as the comprehensive analysis of the gathered information, allowed the researchers to develop an in-depth understanding of the patient blood management industry and its potential opportunities. Additionally, this report offered an in-depth assessment of the government regulations and their engagement, as well as the determination of the market growth prospects during the forecast period.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis/Supply Chain Analysis

6. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT

6.1. Overview

6.2. Instruments

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.1. Blood Processing Devices

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.1.1. Centrifuges

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.1.2. Blood Cell Processors

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.2. Blood Transfusion Devices

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.2.1. Apheresis Machines

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.2.2. Plasma & Plasma Component Separators

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.2.3. Cell Salvage Systems

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.2.4. Others

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.3. Blood Culture Screening Devices

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.3.1. Automated Blood Culture Systems

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.3.2. Supporting Laboratory Equipment

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.4. Diagnostic & Testing Instruments

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.4.1. PCR Instruments

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.4.2. Hematology Analyzers

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.4.3. NGS Platforms

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.4.4. Blood Grouping Analyzers

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.5. Blood Storage Devices

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.5.1. Medical Refrigerators

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.5.2. Medical Freezers

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3. Accessories

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.1. Syringes & Needles

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.2. Vials & Tubes

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.3. Blood Bags

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.4. Others

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.4. Reagents and Kits

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.4.1. Culture Media

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.4.2. Reagents

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.4.3. Kits

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.4.4. Others

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.5. Software

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT

7.1. Overview

7.2. Whole Blood

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

7.3. Plasma

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY END USER

8.1. Overview

8.2. Blood Banks

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

8.3. Hospitals

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

8.4. Diagnostic Clinics and & Pathology Labs

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1.1. Overview

10.1.2. Competitive Analysis

10.1.3. Market Share Analysis

10.1.4. Major Growth Strategy in the global patient blood management market

10.1.5. Competitive Benchmarking

10.1.6. Leading Player in terms of Number of Developments in the global patient blood management market

10.1.7. Key Developments & Growth Strategies

10.1.7.1. Product Launch

10.1.7.2. Merger & Acquisition

10.1.7.3. Joint Ventures

10.1.8. Major Players Financial Matrix

10.1.8.1. Sales & Operating Income 2019

10.1.8.2. Major Players R&D Expenditure 2019

11. COMPANY PROFILES

11.1. Biomérieux SA

11.1.1. Company Overview

11.1.2. Product Type Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Bio-Rad Laboratories, Inc.

11.2.1. Company Overview

11.2.2. Product Type Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Fresenius Se & Co. KGaA

11.3.1. Company Overview

11.3.2. Product Type Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. B. Braun Melsungen AG

11.4.1. Company Overview

11.4.2. Product Type Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Abbott Laboratories

11.5.1. Company Overview

11.5.2. Product Type Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Danaher Corporation

11.6.1. Company Overview

11.6.2. Product Type Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Hitachi, Ltd.

11.7.1. Company Overview

11.7.2. Product Type Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Terumo Corporation

11.8.1. Company Overview

11.8.2. Product Type Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Grifols, S.A

11.9.1. Company Overview

11.9.2. Product Type Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Immucor, Inc.

11.10.1. Company Overview

11.10.2. Product Type Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Others

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SYNOPSIS, 2019–2027

TABLE 2 GLOBAL PATIENT BLOOD MANAGEMENT MARKET ESTIMATES & FORECAST, 2019–2027 (USD MILLION)

TABLE 3 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 4 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 5 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 6 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY REGION, 2019–2027 (USD MILLION)

TABLE 7 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 8 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 9 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 10 US: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 11 US: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 12 US: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 13 CANADA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 14 CANADA: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 15 CANADA: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 16 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 17 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 18 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 19 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 20 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 21 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 25 EASTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 26 EASTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 27 EASTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)  

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PATIENT BLOOD MANAGEMENT MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PATIENT BLOOD MANAGEMENT MARKET

FIGURE 4 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY PRODUCT, 2019 (%)

FIGURE 5 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COMPONENT, 2019 (%)

FIGURE 6 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY END USER, 2019 (%)

FIGURE 7 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY REGION, 2019 (%)

FIGURE 7 AMERICAS: PATIENT BLOOD MANAGEMENT MARKET SHARE BY REGION, 2019 (%)

FIGURE 8 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 9 EUROPE: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY REGION, 2019 (%)

FIGURE 10 WESTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 11 ASIA-PACIFIC: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 12 MIDDLE EAST & AFRICA: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 13 GLOBAL PATIENT BLOOD MANAGEMENT MARKET: COMPANY SHARE ANALYSIS, 2019 (%)

FIGURE 14 BIOMÉRIEUX SA: KEY FINANCIALS

FIGURE 15 BIOMÉRIEUX SA: SEGMENTAL REVENUE

FIGURE 16 BIOMÉRIEUX SA: REGIONAL REVENUE

FIGURE 17 BIO-RAD LABORATORIES, INC.: KEY FINANCIALS

FIGURE 18 BIO-RAD LABORATORIES, INC.: SEGMENTAL REVENUE

FIGURE 19 BIO-RAD LABORATORIES, INC.: REGIONAL REVENUE

FIGURE 20 FRESENIUS SE & CO. KGAA: KEY FINANCIALS

FIGURE 21 FRESENIUS SE & CO. KGAA: SEGMENTAL REVENUE

FIGURE 22 FRESENIUS SE & CO. KGAA: REGIONAL REVENUE

FIGURE 23 B. BRAUN MELSUNGEN AG: KEY FINANCIALS

FIGURE 24 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

FIGURE 25 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE

FIGURE 26 ABBOTT LABORATORIES: KEY FINANCIALS

FIGURE 27 ABBOTT LABORATORIES: SEGMENTAL REVENUE

FIGURE 28 ABBOTT LABORATORIESREGIONAL REVENUE

FIGURE 29 DANAHER CORPORATION: KEY FINANCIALS

FIGURE 30 DANAHER CORPORATION: SEGMENTAL REVENUE

FIGURE 31 DANAHER CORPORATION: REGIONAL REVENUE

FIGURE 32 HITACHI, LTD: KEY FINANCIALS

FIGURE 33 HITACHI, LTD.: SEGMENTAL REVENUE

FIGURE 34 HITACHI, LTD: REGIONAL REVENUE

FIGURE 35 TERUMO CORPORATION.: KEY FINANCIALS

FIGURE 36 TERUMO CORPORATION.: SEGMENTAL REVENUE

FIGURE 37 TERUMO CORPORATION.: REGIONAL REVENUE

FIGURE 38 GRIFOLS, S.A: KEY FINANCIALS

FIGURE 39 GRIFOLS, S.A: SEGMENTAL REVENUE

FIGURE 40 GRIFOLS, S.A: REGIONAL REVENUE

FIGURE 41 IMMUCOR, INC.: KEY FINANCIALS

FIGURE 42 IMMUCOR, INC.: SEGMENTAL REVENUE

FIGURE 43 IMMUCOR, INC.: REGIONAL REVENUE

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.